Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

Ativos Totais de Mersana Therapeutics, Inc..

Dados anuais

2016

2017

2018

2019

2020

2021

2022

2023

‪0,00‬

‪‪90,00 M‬‬

‪‪180,00 M‬‬

‪‪270,00 M‬‬

‪‪360,00 M‬‬

Período

Valor

Variação

Variação %

2023

‪‪226,06 M‬‬

‪‪−108,28 M‬‬

‪−32,39‬%

2022

‪‪334,34 M‬‬

+‪‪128,23 M‬‬

+‪62,21‬%

2021

‪‪206,11 M‬‬

‪‪−67,29 M‬‬

‪−24,61‬%

2020

‪‪273,40 M‬‬

+‪‪165,86 M‬‬

+‪154,23‬%

2019

‪‪107,54 M‬‬

+‪‪29,04 M‬‬

+‪36,99‬%

2018

2017

2016

Dados trimestrais

Q1 '17

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪90,00 M‬‬

‪‪180,00 M‬‬

‪‪270,00 M‬‬

‪‪360,00 M‬‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪169,53 M‬‬

‪‪−9,60 M‬‬

‪−5,36‬%

Q2 '24

‪‪179,13 M‬‬

‪‪−19,25 M‬‬

‪−9,70‬%

Q1 '24

‪‪198,37 M‬‬

‪‪−27,69 M‬‬

‪−12,25‬%

Q4 '23

‪‪226,06 M‬‬

‪‪−36,84 M‬‬

‪−14,01‬%

Q3 '23

‪‪262,90 M‬‬

‪‪−48,10 M‬‬

‪−15,46‬%

Q2 '23

‪‪311,00 M‬‬

+‪‪14,80 M‬‬

+‪5,00‬%

Q1 '23

‪‪296,19 M‬‬

‪‪−38,15 M‬‬

‪−11,41‬%

Q4 '22

‪‪334,34 M‬‬

+‪‪19,49 M‬‬

+‪6,19‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17

Q3 '17

Q2 '17

Q1 '17